azasetron has been researched along with Colorectal Neoplasms in 1 studies
azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ataee, R | 1 |
| Ajdary, S | 1 |
| Zarrindast, M | 1 |
| Rezayat, M | 1 |
| Shokrgozar, MA | 1 |
| Ataee, A | 1 |
1 other study available for azasetron and Colorectal Neoplasms
| Article | Year |
|---|---|
Y25130 hydrochloride, a selective 5HT3 receptor antagonist has potent antimitogenic and apoptotic effect on HT29 colorectal cancer cell line.
Topics: Antimitotic Agents; Apoptosis; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycl | 2010 |